The purpose is to advance a newly discovered antimicrobial metabolite from biodiversity-based research toward practical bioinnovation by integrating microbial genomics, AI-assisted bioinformatics, and experimental validation. By understanding its biosynthetic pathways and improving microbial production, the project aims to establish a scalable platform for next-generation antimicrobial solutions with potential applications in sustainable biotechnology and health-related materials.
